Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Mismatch repair status and the response of human cells to cisplatin.

Mismatch repair status and the response of human cells to cisplatin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Mismatch repair status and the response of human cells to cisplatin. Abstract Text:

    elisabetta paniElisabetta Pani,lovorka stojicLovorka Stojic,mahmoud el-shemerlyMahmoud El-Shemerly,josef jiricnyJosef Jiricny,stefano ferrariStefano Ferrari,

    The emergence of resistance to cisplatin is a serious drawback of cancer therapy. To help elucidate the molecular basis of this resistance, we examined matched ovarian cancer cell lines that differ in their DNA mismatch repair (MMR) status and the response to cisplatin. Checkpoint activation by cisplatin was identical in both lines. However, sensitive cells delayed S-phase transition, arrested at G(2)/M and died by apoptosis. The G(2)/M block was characterized by selective disappearance of homologous recombination (HR) proteins, which likely resulted in incomplete repair of the cisplatin adducts. In contrast, resistant cells transiently arrested at G(2)/M, maintained constant levels of HR proteins and ultimately resumed cell cycle progression. The net contribution of MMR to the cisplatin response was examined using matched semi-isogenic (HCT116+/-chr3) or strictly isogenic (293T-Lalpha(-/+)) cell lines. Delayed transition through S-phase in response to cisplatin was also observed in the MMR-proficient HCT116+chr3 cells. Unlike in the ovarian cell lines, however, both HCT116+chr3 and HCT116 permanently arrested at G(2)/M with an intact complement of HR proteins and died by apoptosis. A similar G(2)/M arrest was observed in the strictly isogenic 293T-Lalpha(-/+) cells. This confirmed that although MMR undoubtedly contributes towards the cytotoxicity of cisplatin, it is only one of several pathways that modulate the cellular response to this drug. However, our data highlighted the importance of HR to cisplatin cytotoxicity and suggested that HR status might represent a novel prognostic marker and possibly also a therapeutic target, the inhibition of which would substantially sensitize cells to cisplatin chemotherapy.

    Mismatch repair status and the response of human cells to cisplatin. Publishing Authors By Initials

    e paniE Pani,l stojicL Stojic,m el-shemerlyM El-Shemerly,j jiricnyJ Jiricny,s ferrariS Ferrari,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Mismatch repair status and the response of human cells to cisplatin. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Cell cycle (Georgetown, Tex.)

    VOLUME: 6

    Page Numbers: 1796-802

    Journal Abbreviation: Cell Cycle

    ISSN: 1551-4005

    DAY: 22

    MONTH: 05

    YEAR: 2007

    Mismatch repair status and the response of human cells to cisplatin. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101137841

    Mismatch repair status and the response of human cells to cisplatin. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Mismatch repair status and the response of human cells to cisplatin. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Mismatch repair status and the response of human cells to cisplatin.

    AFFILIATION: Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cell Cycle

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Mismatch repair status and the response of human cells to cisplatin Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News